Sanofi SA vs Zillow Group Inc Class A — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Zillow Group Inc Class A trades at $31.83 (market cap $7.54B). The key difference: Sanofi SA is far larger — about 13.9× Zillow Group Inc Class A's market cap, and Sanofi SA pays a 5.5% dividend while Zillow Group Inc Class A pays none. Which is the better fit depends on your goals.
| SNY | ZG | |
|---|---|---|
Market Cap | $104.83B | $7.54B |
Sector | Health | Media |
52-Week High | $52.34 | $86.76 |
52-Week Low | $41.33 | $29.14 |
Enterprise Value | $121.32B | $7.19B |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →